Literature DB >> 1347796

Multiple isolates and characteristics of human T-cell leukemia virus type II.

W W Hall1, H Takahashi, C Liu, M H Kaplan, O Scheewind, S Ijichi, K Nagashima, R C Gallo.   

Abstract

Human T-cell leukemia (or lymphotropic) virus type II (HTLV-II) was isolated from eight HTLV-seropositive patients, six of whom were also infected with human immunodeficiency virus, by cocultivation of peripheral blood mononuclear cells (PBMCs) with BJAB, a continuous B-cell line. Restriction endonuclease mapping of the proviruses demonstrated consistent differences among isolates, and two distinct physical map patterns were observed. The results suggest the existence of two closely related molecular subtypes of HTLV-II, which are tentatively designated HTLV-IIa and HTLV-IIb. This finding was supported by preliminary nucleotide sequence analysis of the env gene region encoding the transmembrane glycoprotein gp21, which showed consistent differences between the two proposed virus subtypes. Exploitation of differences in restriction endonuclease sites allowed polymerase chain reaction amplification to detect and differentiate the two subtypes in fresh PBMCs of HTLV-seropositive intravenous drug abusers (IVDAs). The results of these studies confirm that HTLV-II infection is the prominent HTLV infection in seropositive IVDAs and also show that infection with both subtypes occurs. The finding of genetic heterogeneity in the HTLV-II group of viruses may have important implications for studies on its role in human disease and will be useful in characterizing the viruses present in newly discovered endemic foci in New World indigenous populations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347796      PMCID: PMC289041     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

2.  Integrated human T-cell leukemia virus II genome in CD8 + T cells from a patient with "atypical" hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders.

Authors:  J D Rosenblatt; J V Giorgi; D W Golde; J B Ezra; A Wu; C D Winberg; J Glaspy; W Wachsman; I S Chen
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

3.  Rapid progression to AIDS in dual HIV-1/HTLV-I infection.

Authors:  J J Lefrère; A M Couroucé; M Mariotti; E Wattel; O Prou; F Bouchardeau; P Lambin
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

4.  Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad.

Authors:  C Bartholomew; W Blattner; F Cleghorn
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

5.  Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.

Authors:  L Ratner; S F Josephs; B Starcich; B Hahn; G M Shaw; R C Gallo; F Wong-Staal
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

Authors:  M Robert-Guroff; S H Weiss; J A Giron; A M Jennings; H M Ginzburg; I B Margolis; W A Blattner; R C Gallo
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

7.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

Review 8.  Human T-lymphotropic retroviruses.

Authors:  F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

9.  Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates.

Authors:  S Daenke; S Nightingale; J K Cruickshank; C R Bangham
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population.

Authors:  B Hjelle; R Mills; S Swenson; G Mertz; C Key; S Allen
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

View more
  28 in total

1.  Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies.

Authors:  R Ishak; A C R Vallinoto; V N Azevedo; A C P Vicente; W W Hall; M O G Ishak
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

2.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 3.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

4.  Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa.

Authors:  A Gessain; P Mauclère; A Froment; M Biglione; J Y Le Hesran; F Tekaia; J Millan; G de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

5.  Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian.

Authors:  D Pardi; W M Switzer; K G Hadlock; J E Kaplan; R B Lal; T M Folks
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

6.  Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.

Authors:  N Kariya; K Hayashi; H Hoshino; Y Tanaka; T R Koirala; N Ohara; K Miyamoto; T Akagi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Human T-cell lymphotropic virus type 1 tax among American blood donors.

Authors:  D Zucker-Franklin; B A Pancake
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

9.  Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys.

Authors:  Y M Chen; Y J Jang; P J Kanki; Q C Yu; J J Wang; R J Montali; K P Samuel; T S Papas
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

10.  Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II.

Authors:  D K Dube; M P Sherman; N K Saksena; V Bryz-Gornia; J Mendelson; J Love; C B Arnold; T Spicer; S Dube; J B Glaser
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.